Corpus Intelligence IC Memo — SAINT FRANCIS HOSPITAL VINITA 2026-04-26 17:33 UTC
IC Memo — SAINT FRANCIS HOSPITAL VINITA
Investment Committee Memorandum | OK | 35 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SAINT FRANCIS HOSPITAL VINITA

CCN 370237 | CRAIG, OK | 35 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SAINT FRANCIS HOSPITAL VINITA is a 35-bed suburban community hospital in CRAIG, OK with $25.9M in net patient revenue and a 10.2% operating margin. The hospital serves a payer mix of 43.6% Medicare, 17.4% Medicaid, and 39.0% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.2% to 17.5% (+736bps).

Net Revenue HCRIS$25.9M
Current EBITDA COMPUTED$2.6M
Operating Margin COMPUTED10.2%
Occupancy HCRIS23.6%
Revenue / Bed COMPUTED$741K
Net-to-Gross HCRIS24.9%
Distress Probability ML58.1%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
87
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 10.2% places it above the state median. Among 87 size-comparable peers (18-70 beds), the median margin is -9.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-70), prioritizing same-state peers. 87 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SAINT FRANCIS HOSPITAL VINITA (Target)OK35$25.9M10.2%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
COMMUNITY HOSPITALOK45$143.9M21.7%
INTEGRIS CANADIAN VALLEY HOSPIOK66$84.9M4.6%
OKLAHOMA SPINE HOSPITALOK23$79.0M8.4%
JACKSON COUNTY MEMORIAL HOSPITOK49$75.5M-10.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$545K+210bp18mo
Cost to Collect4.5%2.5%$519K+200bp12mo
Denial Rate Reduction12.0%6.5%$513K+198bp12mo
A/R Days Reduction5200.0%3800.0%$316K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$545K
Cost to Collect
$519K
Denial Rate Reduction
$513K
A/R Days Reduction
$316K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$2.6M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$4.5M
Current Margin10.2%
Pro Forma Margin17.5%
WC Released (1x)$995K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.1M$36.5M8.99x55.1%
Base (11x exit)10.0x11.0x$4.1M$41.5M10.21x59.2%
Bull Case9.0x11.0x$3.7M$49.1M13.43x68.1%
Bull (12x exit)9.0x12.0x$3.7M$54.6M14.94x71.8%
Bear Case11.0x10.0x$4.5M$25.6M5.74x41.8%
Bear (11x exit)11.0x11.0x$4.5M$29.7M6.64x46.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 23.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 87 hospitals with 18-70 beds
  • Same-state prioritization (n=88)
  • Comp margins: P25=-24.3% / P50=-9.9% / P75=3.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.